Research Topics
| Gabriele MartelliSummaryAffiliation: Istituto Nazionale Tumori Country: Italy Publications
|
Detail Information
Publications
A randomized trial comparing axillary dissection to no axillary dissection in older patients with T1N0 breast cancer: results after 5 years of follow-upGabriele Martelli
Unit of Diagnostic Oncology and Out Patient Clinic, Istituto Nazionale Tumori, Milan, Italy
Ann Surg 242:1-6; discussion 7-9. 2005..We addressed this issue in a randomized trial comparing axillary dissection with no axillary dissection in older patients with T1N0 breast cancer...
Axillary dissection versus no axillary dissection in elderly patients with breast cancer and no palpable axillary nodes: results after 15 years of follow-upGabriele Martelli
Breast Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
Ann Surg Oncol 18:125-33. 2011..To assess the long-term safety of no axillary clearance in elderly patients with breast cancer and nonpalpable axillary nodes...
Axillary dissection versus no axillary dissection in older patients with T1N0 breast cancer: 15-year results of a randomized controlled trialGabriele Martelli
Breast Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
Ann Surg 256:920-4. 2012..To assess the role of axillary dissection in older breast cancer patients with a clinically clear axilla...
Is axillary lymph node dissection necessary in elderly patients with breast carcinoma who have a clinically uninvolved axilla?Gabriele Martelli
Unit of Diagnostic Oncology and Outpatient Clinic, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy
Cancer 97:1156-63. 2003....
Elderly breast cancer patients treated by conservative surgery alone plus adjuvant tamoxifen: fifteen-year results of a prospective studyGabriele Martelli
Breast Unit, National Cancer Institute, Milan, Italy
Cancer 112:481-8. 2008....
Primary breast cancer in elderly women: biological profile and relation with clinical outcomeMaria Grazia Daidone
Dipartimento di Oncologia Sperimentale, Istituto Nazionale per lo Studio e la Cura dei Tumori, Via Venezian, 1, 20133 Milan, Italy
Crit Rev Oncol Hematol 45:313-25. 2003....
